Evidence map›Paper›PMID 24500771›Full record

ArticleMolecular imaging and biology2014

Breast cancer cells imaging by targeting methionine transporters with gadolinium-based nanoprobe.

Bita Mehravi, Mehdi Shafiee Ardestani, Maryam Damercheli, Haleh Soltanghoraee, Negar Ghanaldarlaki, Ali M Alizadeh, Mohammad A Oghabian, Maryam Shahzad Shirazi, Shabnam Mahernia, Massoud Amanlou

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Acute Toxicity Evaluation of Glycosylated GdMolecular imaging and biology · 2017
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Bita MehraviFaculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mehdi Shafiee Ardestani
Maryam Damercheli
Haleh Soltanghoraee
Negar Ghanaldarlaki
Ali M Alizadeh
Mohammad A Oghabian
Maryam Shahzad Shirazi
Shabnam Mahernia
Massoud Amanlou
Tehran University of Medical Sciences · IRAcademic Center for Education, Culture and Research · IRIran University of Medical Sciences · IRIslamic Azad University, Science and Research Branch · IRSemnan University · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEarly cancer diagnosis using MRI imaging is of high global interest as a non-invasive and powerful modality. In this study, methionine was conjugated on gadolinium-based mesoporous silica nanospheres to evaluate intra-cellular uptake and its accumulation in human breast cancer cells. PROCEDURES: The contrast agent was synthesized and characterized using different techniques including N2 physisorption, thermal gravimetric analysis, dynamic light scattering, and inductively coupled plasma atomic emission spectroscopy (ICP-AES). The intra-cellular uptake of Gd(3+) was measured by ICP-AES, fluorescent microscopy, and flow cytometry. Finally, cellular and tumor MR imaging were performed to determine in vitro and in vivo relaxometry.

resultsAccording to the results, the contrast agents accumulated in tumor cells both in vitro and in vivo. There was no significant cellular toxicity on either normal or cancer cells along with strong intense signal on T 1 compared to the unlabeled cells.

conclusionsThe results showed that the novel contrast agent could become a useful tool in early detection of cancer.

Indexed as

GadoliniumNanospheresBreast NeoplasmsCell SurvivalDiagnostic ImagingFemaleHEK293 CellsHumansIntracellular SpaceMagnetic Resonance ImagingMCF-7 CellsMembrane Transport ProteinsMethioninePorositySilicon DioxideGadoliniumMembrane Transport ProteinsMethionineSilicon Dioxide

Identifiers

PMID24500771
OpenAlexW1972100627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.